CLINICAL_TRIALS
research
· 2026-04-01
Clinical Trial Update: Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN [Phase 3]
Summary
A Phase 3 clinical trial evaluating the efficacy and safety of iptacopan in participants with immune complex membranoproliferative glomerulonephritis (IC-MPGN) …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: IC-MPGN | Phase 3 | Status: RECRUITING